Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
361
datasets available to search
ShareScore release 0.9.0
Dataset results
361 results for “regurgitation”
Data from: The effect of plant identity and mixed feeding on the detection of seed DNA in regurgitates of carabid beetles
Open the record for dataset details and reuse information.
Gene expression profiling in Wistar male rat left ventricle with chronic and severe aortic valve regurgitation
GEO Series GSE17050. Rattus norvegicus. 10 samples. Type: Expression profiling by array.
Exploring Regulatory Mechanisms of Atrial Myocyte Hypertrophy of Mitral Regurgitation through Gene Expression Profiling Analysis: Role of NFAT in Cardiac Hypertrophy
GEO Series GSE63045. Homo sapiens. 10 samples. Type: Expression profiling by array.
Single-cell analysis reveals the loss of progenitor subpopulation of valvular endothelial cells leads to functional mitral regurgitation
GEO Series GSE241947. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
Transcriptomic analysis of cardiac remodelling following minimally invasive surgery for aortic regurgitation
GEO Series GSE252164. Mus musculus. 16 samples. Type: Expression profiling by high throughput sequencing.
Transcriptional Profiling of Normal, Stenotic, and Regurgitant Human Aortic Valves
GEO Series GSE153555. Homo sapiens. 30 samples. Type: Expression profiling by high throughput sequencing.
Mitral valve leaflet response to ischemic mitral regurgitation: From gene expression to tissue remodeling
GEO Series GSE139921. Ovis aries. 12 samples. Type: Expression profiling by high throughput sequencing.
ATRIAL SECONDARY TRICUSPID REGURGITATION
<p><span>Echocardiographic studies prospectively acquired from patients with secondary tricuspid regurgitation (STR) between October 2010 and March 2022. Inclusion criteria were age >18 years and presence of STR. </span><span>Atrial STR was defined by the presence of STR in patients with a clinical history of atrial fibrillation (AF), normal left ventricular (LV) systolic function, normal right ventricular (RV) size and/or function, and pulmonary artery systolic pressure (PASP) lower than 50 mmHg (2). The rest of the patients were included in the ventricular STR phenotype. </span><span>Exclusion criteria were primary TR, cardiac implantable electronic device (CIED)-related TR (leaflet impingement, adherence, etc.), previous TV surgery or transcatheter treatment, pregnancy, poor apical acoustic window with inadequate echocardiographic images, and lack of follow-up data. </span></p> <p><span>The primary study endpoint was the occurrence of death for any cause or hospitalization for HF. Information concerning survival and hospitalization was obtained at regular intervals via (i) telephone interview with the patient, or if deceased, with family members; (ii) contact with the patient’s physician(s); and (iii) review of electronic medical records of regular outpatient visits and hospital admission records. Mortality status was verified independently through the Social Security Death Index and death certificates. Cause of death was determined based on a review of death certificates, post-mortem exam reports when available, medical records for patients who died while hospitalized, and contact of patient’s physician(s), and it was classified as cardiac or non-cardiac death. HF hospitalization was defined as admission for more than 24 hours with a primary diagnosis of HF, characterized by symptoms, signs, laboratory and/or invasive HF findings, and HF-specific treatment implementation. Assignment of clinical events was performed by physicians unaware of the patient's echocardiographic data. For patients without events, the date of last contact was used for survival analysis.</span></p>
Mitralign Percutaneous Annuloplasty System for Chronic Functional Mitral Valve Regurgitation
ClinicalTrials.gov study NCT01740583. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Efficacy and Safety of Venus P-valve to Treat RVOT Stenosis With Pulmonary Regurgitation
ClinicalTrials.gov study NCT02071654. IPD Sharing: Not stated. Countries: 1. Publications: 0.
3-Dimensional Simulation Guided Transcatheter Aortic Valve Replacement in Aortic Regurgitation(DIGITAL)
ClinicalTrials.gov study NCT07398911. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClip® Device
ClinicalTrials.gov study NCT02858245. IPD Sharing: NO. Countries: 1. Publications: 0.
Elemental Diets vs. Semi-solid Diets on Gastric Excretion and Gastroesophageal Regurgitation
ClinicalTrials.gov study NCT02290626. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Surgical Treatments of Tricuspid Valve Regurgitation After Cardiac Surgery
ClinicalTrials.gov study NCT06554119. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Cardiac Remodeling and Prognosis in Secondar Tricuspid Regurgitation
ClinicalTrials.gov study NCT03159923. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prognostic Value of Early Postoperative Right Ventricular Systolic Function in Patients With Isolated Severe Tricuspid Regurgitation
ClinicalTrials.gov study NCT01203137. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Reduction of Mitral Regurgitation With the SATURN Trans-Septal Transcatheter Mitral Valve Replacement (TMVR) System in Patients With Severe Symptomatic Mitral Regurgitation
ClinicalTrials.gov study NCT06414265. IPD Sharing: NO. Countries: 3. Publications: 0.
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)
ClinicalTrials.gov study NCT05848284. IPD Sharing: NO. Countries: 2. Publications: 0.
Serotonin Receptor Blockers in Ischemic Mitral Regurgitation
ClinicalTrials.gov study NCT05469165. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SAPIEN M3 EFS: Early Feasibility Study of the Edwards SAPIEN M3 System for the Treatment of Mitral Regurgitation
ClinicalTrials.gov study NCT03230747. IPD Sharing: NO. Countries: 2. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.